Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders
US-2024199583-A1 · Jun 20, 2024 · US
US10077274B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10077274-B2 |
| Application number | US-201414899389-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 12, 2014 |
| Priority date | Jun 17, 2013 |
| Publication date | Sep 18, 2018 |
| Grant date | Sep 18, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to UV-curing-compatible photochromic single- or double-fused naphthopyrans of the general formulae (I) or (II) and the use thereof in plastics of all kinds, particularly for ophthalmic purposes. The photochromic compounds according to the invention are characterized by their excellent UV-curing compatibility, i.e. they remain undamaged—incorporated, for example, in an acrylate monomer matrix with UV initiator—by a free-radical polymerization of the matrix initiated by strong UV light. The photochromic dyes according to the invention, by means of suitable choice of substituents, are in addition characterized by two distinct absorption bands of the open form in the visible wavelength range, i.e. two conventional photochromic dyes, each having one discrete absorption band, can be replaced with a molecule of this type.
Opening claim text (preview).
The invention claimed is: 1. A photochromic fused naphthopyran according to the general formula (III): where the residue R 1 is a (C 1 -C 6 )-alkyl residue or a phenyl residue; the residue R 3 is hydrogen, a (C 1 -C 6 )-alkyl residue or a phenyl residue; and and where B and B′ are mutually independently selected from one of the following groups a) or b), where a) is an unsubstituted, mono-, di- and trisubstituted aryl residue, wherein the aryl residue is phenyl, naphthyl or phenanthryl and b) is an unsubstituted, mono- and disubstituted heteroaryl residue, wherein the heteroaryl residue is pyridyl, furanyl, thienyl, benzofuranyl, benzothienyl, 1,2,3,4-tetrahydrocarbazolyl and julolidinyl; wherein the substituents of the aryl and heteroaryl residues in a) and b) are selected from the group α consisting of a hydrogen atom, a (C 1 -C 6 )-alkyl residue, a (C 1 -C 6 )-thioalkyl residue, a (C 3 -C 7 )-cycloalkyl residue which may have one or more heteroatoms such as O or S, a (C 1 -C 6 )-alkoxy residue, a hydroxyl group, a trifluoromethyl group, bromine, chlorine, fluorine, an unsubstituted, mono- or disubstituted phenyl, phenoxy, benzyl, benzyloxy, naphthyl or naphthoxy residue, or from the group χ consisting of amino, mono-(C 1 -C 6 )-alkylamino, di-(C 1 -C 6 )-alkylamino, phenethenyl unsubstituted, mono- or disubstituted on the phenyl ring, unsubstituted, mono- or disubstituted (phenylimino)methylene, unsubstituted, mono- or disubstituted (phenylmethylene)imino and unsubstituted, mono- or disubstituted mono- and diphenylamino, piperidinyl, 3,5-dimethylpiperidinyl, N-substituted piperazinyl, pyrrolidinyl, imidazolidinyl, pyrazolidinyl, indolinyl, morpholinyl, 2,6-dimethylmorpholinyl, thiomorpholinyl, azacycloheptyl, azacyclooctyl, unsubstituted, mono- or disubstituted phenothiazinyl, unsubstituted, mono- or disubstituted phenoxazinyl, unsubstituted, mono-, di- or trisubstituted 9,10-dihydroacridinyl, unsubstituted, mono- or disubstituted 1,2,3,4-tetrahydroquinolinyl, unsubstituted, mono- or disubstituted 2,3-dihydro-1,4-benzoxazinyl, unsubstituted, mono- or disubstituted 1,2,3,4-tetrahydroisoquinolinyl, unsubstituted, mono- or disubstituted phenazinyl, unsubstituted, mono- or disubstituted carbazolyl, unsubstituted, mono- or disubstituted 1,2,3,4-tetrahydrocarbazolyl and unsubstituted, mono- or disubstituted 10,11-dihydrodibenz[b,f]azepinyl, wherein the substituent(s) may in turn be mutually independently selected from the group α; or wherein two directly adjacent substituents of the aryl and heteroaryl residues in a) and b) are a V—(CR 8 R 9 ) p —W moiety, where p=1, 2 or 3, the residues R 8 and R 9 are each mutually independently a substituent selected from the group α, and also V and W are mutually independently selected from the moieties —O—, —S—, —N(C 1 -C 6 )-alkyl, —NC 6 H 5 -, —CH 2 —, —C(CH 3 ) 2 —or —C(C 6 H 5 ) 2 —; or two or more adjacent —CR 8 R 9 moieties are part of a fused benzene ring, which may be unsubstituted, mono- or disubstituted, wherein the substituents may in turn be selected from the group α; or V and/or W together with the respective adjacent —CR 8 R 9 moiety is a fused benzene ring, which may be unsubstituted, mono- or disubstituted, wherein the substituents may in turn be selected from the group α. 2. The photochromic fused naphthopyran as claimed in claim 1 , which are: 3,3-bis(4-methoxyphenyl)-6,7-ethylenedioxy-13-phenyl-14-methyl-13,14-dihydro-naphtho[2,1-d]naphtho[1,2-b]pyran; 3,3-bis(4-methoxyphenyl)-6,7-ethylenedioxy-13-phenyl-13,14-dimethyl-13,14-dihydro-naphtho[2,1-d]naphtho[1,2-b]pyran; 3,3-bis(4-ethoxyphenyl)-6,7-ethylenedioxy-13-phenyl-14-methyl-13,14-dihydro-naphtho[2,1-d]naphtho[1,2-b]pyran; 3,3-bis(4-ethoxyphenyl)-6,7-ethylenedioxy-13-phenyl-13,14-dimethyl-13,14-dihydro-naphtho[2,1-d]naphtho[1,2-b]pyran; 3-(4-methoxyphenyl)-3-phenyl-6,7-ethylenedioxy-13-phenyl-14-methyl-13,14-dihydro-naphtho[2,1-d]naphtho[1,2-b]pyran; 3-(4-methoxyphenyl)-3-phenyl-6,7-ethylenedioxy-13-phenyl-13,14-dimethyl-13,14-dihydro-naphtho[2,1-d]naphtho[1,2-b]pyran; 3-(4-ethoxyphenyl)-3-phenyl-6,7-ethylenedioxy-13-phenyl-14-methyl-13,14-dihydro-naphtho[2,1-d]naphtho[1,2-b]pyran; 3-(4-ethoxyphenyl)-3-phenyl-6,7-ethylenedioxy-13-phenyl-13,14-dimethyl-13,14-dihydro-naphtho[2,1-d]naphtho[1,2-b]pyran; 3-(4-butoxyphenyl)-3-phenyl-6,7-ethylenedioxy-13-phenyl-14-methyl-13,14-dihydro-naphtho[2,1-d]naphtho[1,2-b]pyran; or 3-(4-butoxyphenyl)-3-phenyl-6,7-ethylenedioxy-13-phenyl-13,14-dimethyl-13,14-dihydro-naphtho[2,1-d]naphtho[1,2-b]pyran. 3. The photochromic fused naphthopyran as claimed in claim 1 , wherein the residues B and B′ are mutually independently selected from the group a), as defined above. 4. A plastic material comprising the photochromic fused naphthopyran as claimed in claim 1 , wherein the photochromic material is disposed in the plastic material, disposed in a coating on a surface of the plastic material, or provided as a separate layer disposed between adjacent layers of the plastic material. 5. The plastic material as claimed in claim 4 , wherein the plastic material is an ophthalmic lens.
Photochromic filters · CPC title
Six-membered rings · CPC title
Photochromic filters · CPC title
Ortho-condensed systems · CPC title
Ophthalmic lenses having special refractive features achieved by special materials or material structures (G02C7/049 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.